Gene · 5015
Papers2,975
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,975
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins. | Res Sq | 2023 | 37461708 | PubTator, text mining | PubMed |
| Dissecting peri-implantation development using cultured human embryos and embryo-like assembloids. | Cell Res | 2023 | 37460804 | PubTator, text mining | PubMed |
| A multilayered approach to the analysis of genetic data from individuals with suspected albinism. | J Med Genet | 2023 | 37460203 | PubTator, text mining | PubMed |
| Fabrication of functional ameloblasts from hiPSCs for dental application. | Front Cell Dev Biol | 2023 | 37457296 | PubTator, text mining | PubMed |
| A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37451260 | PubTator, text mining | PubMed |
Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders. | Int J Mol Sci | 2023 | 37445940 | PubTator, text mining | PubMed |
| Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors. | Cancers (Basel) | 2023 | 37444642 | PubTator, text mining | PubMed |
Identification of signaling pathways modifying human dopaminergic neuron development using a pluripotent stem cell-based high-throughput screening automated system: purinergic pathways as a proof-of-principle. | Front Pharmacol | 2023 | 37435497 | PubTator, text mining | PubMed |
| A critical role for heme synthesis and succinate in the regulation of pluripotent states transitions. | Elife | 2023 | 37428012 | PubTator, text mining | PubMed |
| Molecular mechanisms controlling vertebrate retinal patterning, neurogenesis, and cell fate specification. | Trends Genet | 2023 | 37423870 | PubTator, text mining | PubMed |
| Plakoglobin is a mechanoresponsive regulator of naive pluripotency. | Nat Commun | 2023 | 37419903 | PubTator, text mining | PubMed |
| Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. | Indian J Ophthalmol | 2023 | 37417104 | PubTator, text mining | PubMed |
| Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. | Cells | 2023 | 37408278 | PubTator, text mining | PubMed |
| Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects. | Stem Cell Res | 2023 | 37393719 | PubTator, text mining | PubMed |
| Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. | Cell Death Discov | 2023 | 37393356 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line (NCHi010-A) from a 6-year-old female with Down syndrome and without congenital heart disease. | Stem Cell Res | 2023 | 37392705 | PubTator, text mining | PubMed |
| Spinal Cord Organoids to Study Motor Neuron Development and Disease. | Life (Basel) | 2023 | 37374039 | PubTator, text mining | PubMed |
| Management of Neonatal Isolated and Combined Growth Hormone Deficiency: Current Status. | Int J Mol Sci | 2023 | 37373261 | PubTator, text mining | PubMed |
| The Emerging Roles of the Cephalic Neural Crest in Brain Development and Developmental Encephalopathies. | Int J Mol Sci | 2023 | 37372994 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review. | Cancers (Basel) | 2023 | 37370764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5015/papers?page=16